Copyright: ©Author(s) 2026.
World J Stem Cells. May 26, 2026; 18(5): 119123
Published online May 26, 2026. doi: 10.4252/wjsc.v18.i5.119123
Published online May 26, 2026. doi: 10.4252/wjsc.v18.i5.119123
Figure 1 Kaplan-Meier curve of recurrence-free survival of patients with high-expression and low-expression cancer stem cells.
CSC: Cancer stem cell.
Figure 2 Kaplan-Meier curves of CK19 expression and overall survival rate.
A: Overall survival; B: Recurrence-free survival.
Figure 3 Comparison of prediction performance of the clinical model and the combined clinical + cancer stem cell marker model.
A: For 3-year recurrence prediction; B: For 3-year mortality prediction. CSC: Cancer stem cell; AUC: Area under the curve.
- Citation: Jia XQ, Han S, Shang YS, Kong FG, Qi L, Wang CL, Xiong WJ. Expression of liver cancer stem cell markers and association with recurrence and survival in hepatocellular carcinoma. World J Stem Cells 2026; 18(5): 119123
- URL: https://www.wjgnet.com/1948-0210/full/v18/i5/119123.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v18.i5.119123